Stay updated on Fremanezumab in Preventing Chronic Migraine Clinical Trial

Sign up to get notified when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fremanezumab in Preventing Chronic Migraine Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the history, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T02:20:57.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Added revision v3.4.2. Removed the funding-status notice and the earlier revision v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T14:13:45.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding status and updated the page revision to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:25:16.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    UI updates include showing the glossary option, color‑coding explanations (green for additions, red for deletions), and revision notes updating from v3.3.4 to v3.4.0.
    Difference
    0.4%
    Check dated 2026-01-28T05:49:00.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The history now includes a new Revision: v3.3.4 and removes Revision: v3.3.3, reflecting a minor administrative update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:27:44.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Results Posted including Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and updated Study Status (Revision: v3.3.3, 2025-12-19). Previous entry 'Results Submitted' and 'HHS Vulnerability Disclosure' removed (Revision: v3.3.2, 2025-10-28).
    Difference
    0.5%
    Check dated 2025-12-23T12:27:13.000Z thumbnail image

Stay in the know with updates to Fremanezumab in Preventing Chronic Migraine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.